Globus Medical, Inc. Class A Common Stock (NY:GMED)

75.60 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

15 16 Next >

Stryker Had A Good Year Last Year; Here's How It's Looking For 2025 ↗

January 13, 2025

Reflecting its strong growth, on Monday the Relative Strength (RS) Rating for Stryker stock got an upgrade from 70 to 74.

Via Investor's Business Daily

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

January 08, 2025

From Globus Medical

Via GlobeNewswire

The Law Offices of Frank R. Cruz Continues Its Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors

January 08, 2025

From The Law Offices of Frank R. Cruz

Via Business Wire

Inspire Medical's Sleep Innovations Driving Big Gains ↗

January 08, 2025

Inspire Medical, which makes innovative apnea relief devices, hit a key performance benchmark as its Relative Strength Rating jumped to 81.

Via Investor's Business Daily

Price Over Earnings Overview: Globus Medical ↗

January 06, 2025

Via Benzinga

Why GLOBUS MEDICAL INC - A (NYSE:GMED) qualifies as a high growth stock. ↗

December 31, 2024

Delving into GLOBUS MEDICAL INC - A (NYSE:GMED)'s high Growth Prospects.

Via Chartmill

16 Analysts Have This To Say About Globus Medical ↗

December 18, 2024

Via Benzinga

Lantheus Stock Doubled In A Year Amid Wide Use Of Its AI-Enabled Medical Devices ↗

January 07, 2025

Lantheus Holdings sees its Relative Strength Rating reach the 80-plus level.

Via Investor's Business Daily

Inari Medical Stock Gets RS Rating Upgrade ↗

December 11, 2024

On Wednesday, Inari Medical stock received an upgrade to its Relative Strength (RS) Rating, from 65 to 72.

Via Investor's Business Daily

Should you consider GLOBUS MEDICAL INC - A (NYSE:GMED) for high growth investing? ↗

December 10, 2024

Unlocking the high Growth Potential of GLOBUS MEDICAL INC - A (NYSE:GMED).

Via Chartmill

Novocure Stock Earns 96 RS Rating ↗

December 03, 2024

On Tuesday, Novocure stock got a positive adjustment to its Relative Strength (RS) Rating to 96, up from 73.

Via Investor's Business Daily

Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos ↗

December 02, 2024

Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.

Via Benzinga

Evaluating Globus Medical: Insights From 11 Financial Analysts ↗

December 02, 2024

Via Benzinga

What 7 Analyst Ratings Have To Say About Globus Medical ↗

November 06, 2024

Via Benzinga

The Analyst Verdict: Globus Medical In The Eyes Of 7 Experts ↗

October 14, 2024

Via Benzinga

Globus Medical Launches ExcelsiusHub™ Navigation System

November 22, 2024

From Globus Medical

Via GlobeNewswire

Despite its growth, NYSE:GMED remains within the realm of affordability. ↗

November 07, 2024

GLOBUS MEDICAL INC - A (NYSE:GMED) stands out as a growth opportunity that won't break the bank.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 06, 2024

Via Benzinga

CVS Health, Johnson Controls And 3 Stocks To Watch Heading Into Wednesday ↗

November 06, 2024

Via Benzinga

Globus Medical (GMED) Q3 2024 Earnings Call Transcript ↗

November 05, 2024

GMED earnings call for the period ending September 30, 2024.

Via The Motley Fool

Topics Earnings

NYSE:GMED is showing good growth, while it is not too expensive. ↗

October 02, 2024

In the world of growth stocks, NYSE:GMED shines as a value proposition.

Via Chartmill

Looking Into Globus Medical's Recent Short Interest ↗

September 06, 2024

Via Benzinga

Globus Medical Reports Third Quarter 2024 Results

November 05, 2024

From Globus Medical

Via GlobeNewswire

Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting

October 18, 2024

From Globus Medical

Via GlobeNewswire

Globus Medical Schedules Third Quarter Earnings Release and Conference Call

October 15, 2024

From Globus Medical

Via GlobeNewswire

Globus Medical Launches the Next Wave of Orthopedic Trauma Solutions

October 02, 2024

From Globus Medical

Via GlobeNewswire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 23, 2024

Via Benzinga

Bragar Eagel & Squire, P.C. Is Investigating MaxLinear, Customers Bancorp, Globus, and Metagenomi and Encourages Investors to Contact the Firm

September 20, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

While growth is established for NYSE:GMED, the stock's valuation remains reasonable. ↗

September 11, 2024

While growth is established for NYSE:GMED, the stock's valuation remains reasonable.

Via Chartmill

Bragar Eagel & Squire, P.C. Is Investigating MaxLinear, Customers Bancorp, Globus, and Domino’s and Encourages Investors to Contact the Firm

September 09, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.